| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |